Alli Marketing: While Vitamins Are Friendly, Some Supplements Are Foes
This article was originally published in The Tan Sheet
Executive Summary
Glaxo is positioning alli, with its gradual weight-loss claim and its "program, not a pill" support plan, as an FDA-approved alternative to dietary supplements
You may also be interested in...
Petition Requests Pre-Market Approval For Supplement Weight-Loss Claims
Manufacturers would need pre-market approval to make weight-loss claims for supplements if FDA implements a rulemaking recommended by petitioners, including GlaxoSmithKline, the manufacturer of OTC weight-loss drug alli.
Top Stories Of 2007: From Talk Of BTC To Supplement GMPs
The past year offered anticipated changes and moves as well as some unexpected thrills and chills for the nonprescription drugs and nutritional products industries
Alli Marketing Stresses Education, With Emphasis On Minority Groups – GSK
GlaxoSmithKline’s marketing strategy for its OTC weight-loss drug alli focuses on guiding consumers, particularly African Americans and Hispanics, in deciding whether they will follow the usage protocol before they buy the first-in-class product.